Can you explain the TIMI (Thrombolysis In Myocardial Infarction) grading system for coronary artery blood flow?

TIMI Grading System for Coronary Artery Blood Flow

The TIMI (Thrombolysis In Myocardial Infarction) grading system is a 0–3 angiographic scale that quantifies coronary perfusion after acute myocardial infarction, with only TIMI 3 flow (complete, brisk perfusion) associated with optimal myocardial salvage and the lowest mortality.

TIMI Flow Grade Definitions

The TIMI perfusion grading system classifies coronary blood flow into four categories based on angiographic appearance:

• TIMI 0 (No Perfusion): Complete occlusion with no antegrade flow beyond the point of obstruction. 1

• TIMI 1 (Penetration Without Perfusion): Contrast material passes beyond the obstruction but fails to opacify the entire distal coronary bed during the filming sequence. 1

• TIMI 2 (Partial Perfusion): Contrast material opacifies the entire distal coronary bed, but the rate of entry and clearance is noticeably slower than in comparable areas not perfused by the culprit vessel—typically requiring more than 3 cardiac cycles for complete opacification. 2, 3

• TIMI 3 (Complete Perfusion): Antegrade flow into the distal coronary bed occurs as promptly as flow into the bed proximal to the obstruction, with complete filling and clearance of contrast at a normal rate (typically within 3 cardiac cycles or approximately 0.93 ± 0.34 cardiac cycles in normal arteries). 1, 3

Clinical Significance and Mortality Outcomes

TIMI 3 flow is the only grade associated with significantly improved survival and myocardial salvage; TIMI 2 flow behaves functionally like an occluded artery (TIMI 0/1) despite angiographic contrast passage. 1, 2

Mortality Rates by TIMI Grade (90-Minute Post-Thrombolysis):

• TIMI 3: 3.7% mortality 4
• TIMI 2: 6.6% mortality (significantly higher than TIMI 3, p = 0.0003) 4
• TIMI 0/1: 9.2% mortality (significantly higher than TIMI 3, p < 0.0001) 4

Key Functional Differences:

TIMI 3 versus TIMI 0–2 patients demonstrate:

• Higher left ventricular ejection fraction at 1 week (54% vs. 49%, p = 0.006) and 1 month (54% vs. 49%, p = 0.01) 1
• Greater infarct-zone ejection fraction at 1 week (41% vs. 33%, p = 0.003) and 1 month (42% vs. 32%, p = 0.003) 1
• Smaller enzyme peaks (particularly lactate dehydrogenase) and shorter time-to-peak for all cardiac enzymes 1
• Smaller QRS scores at discharge and 1 month, indicating less myocardial necrosis 1
• Lower morbidity index overall 1

Critical Pitfall: TIMI 2 Is Not Adequate Reperfusion

TIMI 2 flow does not differ significantly from TIMI 0/1 in enzymatic peaks, time-to-peak enzyme activity, ST-segment evolution, Q-wave development, or R-wave changes—it functions as a mostly occluded artery despite visible contrast passage. 2

• Patients with TIMI 2 flow have myocardial infarction indices similar to those with complete occlusion (TIMI 0/1). 2
• Only early achievement of TIMI 3 flow results in optimal myocardial salvage. 2
• Clinical implication: Thrombolytic or PCI success should be defined exclusively by achieving TIMI 3 flow, not TIMI 2. 2

Correlation with Intracoronary Doppler Flow Velocity

Angiographic TIMI grading correlates with physiologic coronary flow velocity, but TIMI 2 and TIMI 0/1 have overlapping low-velocity profiles:

• TIMI 0–2: Mean flow velocity 9.4 ± 5.4 cm/s 5
• TIMI 3: Mean flow velocity 16.0 ± 5.4 cm/s (p < 0.05 vs. TIMI ≤2) 5
• Post-PCI, TIMI 3 flow increases to 21.8 ± 10.9 cm/s, whereas TIMI ≤2 remains low (<20 cm/s). 5
• Nine of 11 clinical events (unstable angina, need for CABG) occurred in patients with low coronary flow velocity (<20 cm/s), regardless of angiographic TIMI grade. 5

Primary PCI Outcomes and TIMI 3 Flow

Primary percutaneous coronary intervention (PCI) produces higher rates of TIMI 3 flow compared to fibrinolytic therapy, translating into lower rates of recurrent ischemia, reinfarction, intracranial hemorrhage, and death. 6

• "No-reflow" phenomenon (suboptimal myocardial perfusion despite restoration of epicardial TIMI 3 flow) is associated with reduced survival and results from inflammation, endothelial injury, edema, atheroembolization, and vasospasm. 6
• Manual thrombus aspiration during primary PCI improves tissue perfusion and ST-segment resolution in some studies, though results are inconsistent. 6

Methodologic Considerations and Standardization

The original TIMI 3 definition (flow as prompt as proximal flow) is more stringent than the "3 cardiac cycle" criterion, which inflates TIMI 3 rates by approximately 10%. 3

• In normal coronary arteries, dye traverses the vessel in a mean of 0.93 ± 0.34 cardiac cycles (median 0.80, maximum 2.1, none >3.0). 3
• The 3-cardiac-cycle definition (approximately 2.36 seconds at a heart rate of 79.6 bpm) lies 6 standard deviations above normal and results in TIMI 3 rates of 66.8% versus 57.3% with the original definition (p < 0.001). 3
• Clinical implication: When comparing trial results, apply a ~10% correction factor if the 3-cardiac-cycle definition was used. 3

Practical Algorithm for TIMI Grading During Angiography

1. Inject contrast and observe distal coronary bed opacification:

   • No flow beyond obstruction → TIMI 0
   • Contrast passes obstruction but does not fill distal bed → TIMI 1
   • Distal bed fills completely but slowly (>3 cardiac cycles) → TIMI 2
   • Distal bed fills as rapidly as proximal bed (≤3 cardiac cycles, ideally <1 cycle) → TIMI 3 1, 3

2. If TIMI 2 is achieved post-intervention:

   • Do not consider this adequate reperfusion. 2
   • Consider additional intervention (e.g., thrombectomy, GP IIb/IIIa inhibitors, vasodilators) to achieve TIMI 3 flow. 6

3. If TIMI 3 is achieved but clinical instability persists:

   • Suspect "no-reflow" phenomenon (microvascular obstruction despite epicardial patency). 6
   • Consider intracoronary vasodilators (adenosine, verapamil, nitroprusside) or GP IIb/IIIa antagonists (abciximab). 6

Common Pitfalls to Avoid

• Equating TIMI 2 with successful reperfusion: TIMI 2 confers a mortality benefit over TIMI 0/1 (6.6% vs. 9.2%, p = 0.02) but remains significantly worse than TIMI 3 (3.7%, p = 0.0003). 4
• Ignoring the "no-reflow" phenomenon: Achieving angiographic TIMI 3 flow does not guarantee myocardial tissue-level perfusion; assess ST-segment resolution and consider adjunctive therapies if clinical markers suggest ongoing ischemia. 6
• Performing PCI on non-infarct arteries with TIMI 3 flow in stable patients: This is associated with worse outcomes and should be avoided unless ECG localization is ambiguous or the patient is in cardiogenic shock. 6